Director, CMC Quality, Remote

Pulmovant is a Roivant-backed clinical-stage biotechnology company developing innovative therapies for patients suffering from pulmonary diseases. Pulmovant’s first program, mosliciguat is designed to provide an effective, once-daily, inhaled treatment option for patients with pulmonary hypertension (PH). Mosliciguat is a novel, potential first-in-class, sGC activator with a differentiated mechanism that may have broad applicability across the PH spectrum.

Mosliciguat has been extensively characterized across a robust Phase 1 program with 170 participants dosed to date including patients with PH in the Phase 1b ATMOS study which has produced highly compelling and clinically meaningful efficacy data, as well as a favorable safety profile. Enrollment in a phase 2 trial is ongoing.

As part of the Roivant family of companies, Pulmovant leverages the power of collaboration and innovation to drive progress.

The Director, CMC Quality will be responsible for providing quality oversight and direction to Pulmovant's vendors to ensure that drug substance, drug product, and finished product are manufactured, tested, released, and distributed in compliance with current Good Manufacturing Practices (cGMPs). This is an individual contributor role within a lean QA team, requiring someone who thrives in a small‑company environment and is comfortable being hands‑on across all aspects of CMC quality.

The role demands a strategic yet highly practical approach to quality systems, vendor oversight, and multi‑regional regulatory compliance in support of Pulmovant's global clinical development program.

• Ensure that manufacturing operations at Contract Manufacturing Organizations (CMOs) and partners comply with regulatory requirements and internal Pulmovant quality standards.
• Lead clinical lot disposition and batch record review, ensuring product are released in compliance with Pulmovant procedures, applicable regional requirements, and support QP certification and governance activities at contract manufacturing partners for ex‑US clinical trials.
• Oversee GMP Quality Systems activities at external partners, including deviations, investigations, cAPAs, change controls, and OOS/OOT investigations ensuring timely and compliance execution and closure.
• Conduct and document cGMP audits of vendors, CMOs, contract testing laboratories, contract packaging/labeling, and logistics providers. Negotiate and maintain Quality Agreements with external partners.
• Provide quality and technical input to cross‑functional project teams, and review internal and external documentation including protocols, reports, test methods, specifications, master batch records, and SOPs.
• Partner with CMC, Supply Chain, and Regulatory Affairs to assess overall product quality performance, identify product‑specific quality and compliance risks, and develop risk‑mitigation plans.
• Lead quality initiatives including regulatory inspection preparation and ongoing inspection readiness activities.
• Support the review of CMC sections of regulatory submissions, including INDs and IMPDs, and contribute to responses to health authority questions related to manufacturing and quality.

• BA/BS degree in Chemistry, Biology, or Life Sciences with at least 8 years of experience in the pharmaceutical industry

• Demonstrated knowledge of Quality Systems and cGMP within a regulated environment.
• Demonstrated knowledge of Good Distribution Practices.
• Auditing experience is required.
• Demonstrated experience providing quality oversight of CMOs, including audits, batch review, and issue resolution.
• Analytically strong with practical knowledge of how to identify key performance metrics and quality indicators…